Video

What is the Future of Biosimilars?

Author(s):

Davy James, Managing Editor

CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.

CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.

Related Videos
Related Content
NCCN Flash Update: Changes to Colon Cancer Guidelines, Version 3.2025
April 25th 2025

NCCN Flash Update: Changes to Colon Cancer Guidelines, Version 3.2025

Alana Hippensteele, Lead Editor
Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange
April 14th 2025

Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange

Alexandra Gerlach, Associate Editor
Las Vegas strip, Aerial view
April 25th 2025

Asembia's AXS25 Summit: Must-See Sessions, Expert Interviews as Specialty Pharmacy Gathers

Luke Halpern, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Gout tophus, photomicrograph showing amorphous, eosinophilic material with a foreign-body giant cell reaction and inflammation
April 25th 2025

JAK1 Inhibitor NS-229 Granted FDA Orphan Drug Designation to Treat Allergic Autoimmune Condition

Luke Halpern, Assistant Editor
3D visualization of breast cancer cell metastasis | Image Credit: © freshidea - stock.adobe.com
April 25th 2025

Pyrotinib-Based Therapy May Improve Survival in Patients With HER2+ Breast Cancer and Liver Metastases

Alexandra Gerlach, Associate Editor